Jimmy
banner
jimmymm.bsky.social
Jimmy
@jimmymm.bsky.social
Hematologist at Cleveland Clinic. APD for Heme/Onc Fellowship Program. Interested in medical education and LGBTQ+ health. 🏳️‍🌈🩸#HemeSky
Reposted by Jimmy
If this person sat next to you on a bus or train and started ranting about Bruce Springsteen in this way, you would get up and move to a different seat.

In the United States, we have him the nuclear codes.
May 16, 2025 at 2:47 PM
Reposted by Jimmy
Science does not work like this. The only way you can set a timeline is if you have rigged the results in advance.
April 10, 2025 at 9:55 PM
Reposted by Jimmy
They were careless people, Tom and Daisy- they smashed up things and creatures and then retreated back into their money or their vast carelessness or whatever it was that kept them together, and let other people clean up the mess they had made.

-FS Fitzgerald, The Great Gatsby, published 4/10/1925.
April 10, 2025 at 12:32 PM
Reposted by Jimmy
The worst catastrophes of history are caused by men who are malevolent, ignorant, and have exceptional wills.
April 7, 2025 at 12:51 PM
Reposted by Jimmy
Just learned that the entire division of blood disorders at the CDC was put on administrative leave or terminated effective immediately.

The people who figured out HIV was infecting people through the blood supply.

What could possibly go wrong?
April 1, 2025 at 8:37 PM
Reposted by Jimmy
“This is our documentary moment” @janefonda.com
February 24, 2025 at 4:26 PM
Reposted by Jimmy
Cleveland, Ohio Lit Tonight in Solidarity with Ukraine
February 25, 2025 at 3:01 AM
Reposted by Jimmy
New plan to fight back against private insurance denials:

Doctors when you plan to retire, go get hired by UHC, Anthem, etc, and then once you are in the door, approve absolutely everything until you are fired.
February 22, 2025 at 4:01 PM
Reposted by Jimmy
Ice Melting on the Cuyahoga River in Cleveland, Ohio
February 7, 2025 at 1:46 PM
Reposted by Jimmy
Hey man sorry to hear about all your political turmoil. Would it help if I scrolled around on the computer all day and drove myself insane?
February 6, 2025 at 1:54 PM
Reposted by Jimmy
Viewpoint: Medical students and residents need to be educated on health policy issues like insurance, payment models, and drug regulation to better understand the factors that impact patient health outcomes.

https://ja.ma/3BuTE7P
December 26, 2024 at 12:00 PM
Reposted by Jimmy
Updates on #hemophilia gene therapy! 🩸 🧬

4 years post-treatment, valoctocogene roxaparvovec shows sustained bleed reduction, FVIII expression, and improved quality of life in severe hemophilia A patients. Safety remains acceptable, though some resumed prophylaxis.

https://buff.ly/3BBy3ui
December 19, 2024 at 4:48 PM
Reposted by Jimmy
That feeling when you see your former @ash-hematology.bsky.social mentee in systems-based hematology publishes a GREAT study on iron deficiency anemia in @bloodadvances.bsky.social. I'M SO PROUD OF YOU DR. COGAN!!!
doi.org/10.1182/bloo...
Iron deficiency resolution and time to resolution in an American health system
Key PointsIn a statewide cohort, time to resolution of iron deficiency was 1.9 years, and 58% of patients did not achieve resolution within 3 years.Greater
doi.org
December 18, 2024 at 1:37 AM
Reposted by Jimmy
New in CA: A Cancer Journal for Clinicians! 📕 This review offers practical recommendations for delivering quality cancer care to transgender & gender-diverse individuals. Read for free: acsjournals.onlinelibrary.wiley.com/doi/10.3322/... @drdonsdizon.bsky.social @oncoalert.bsky.social #oncsky
December 10, 2024 at 2:11 PM
Reposted by Jimmy
Is it allowed to say we had a fantastic educational session on #hormone related #VTE with Dr Leslie Skeith and Dr Joseph Shatzel #ASH24? A packed room and loads of interaction. Sorry we couldn’t handle all online questions 🤷🏻‍♀️.
December 10, 2024 at 12:36 AM
Reposted by Jimmy
#ASH24 #bmtsm Brissot: EBMT analysis of haplo <40yo vs MSD >50yo allo in ALL pts age 45+, all in CR1. Similar outcomes for RFS/OS. More relapse with MSD, more NRM with haplo — effects cancel each other for long term outcomes.
December 8, 2024 at 6:31 PM
Reposted by Jimmy
An amazing oral presentation of our #AMLsm #AYA #healthdisparities work by super-star resident Dr. Erin Feliciano 🌟#ASH24 #ASHTrainee #ASHKudos @ash-hematology.bsky.social

A 🧵 on some of the highlights of our findings:

1/x
December 8, 2024 at 6:40 PM
We appreciate the opportunity to present real-world data on thrombosis risk among patients with breast cancer who are receiving targeted therapies- it’s higher than expected! #ASH24 #HemeSky #bcsm
December 8, 2024 at 4:07 AM
Reposted by Jimmy
Session on genetic risk factors for #VTE #ASH24. First abstract presentation on ARIC cohort. CHIP (clonal hematopoiesis of indeterminate potential) is not rare but only modest increase for VTE in older adults. Key message: not worth screening for it.
December 7, 2024 at 5:43 PM
Reposted by Jimmy
Honorable mention #MajorPROsASH: PROs pts with bleeding d/o of unknown cause (BDUC)
- 97 pts completed RAND-36
- significantly worse phys health, energy, social fxn & pain in BDUC vs general population
Important findings in wholly understudied pt population. #ASH24 #hemetwitter
December 7, 2024 at 7:42 PM
Reposted by Jimmy
🩸Platelets!

Lifespan 7-10 days
150-450 × 10⁹/L
Stimulated by TPO
1/3 sequestered in spleen

Receptors:
GpIIbIIIa -> fibrinogen
GPIb-IX-V -> vWF
P2Y12 -> ADP

Granules:
Alpha = fibrinogen, vWF, V, VEGF, PF4, PDGF, P-selectin
Dense = ADP, Ca, Serotonin
#hemesky #MedSky

van der Meijden et al, 2019
December 1, 2024 at 1:05 PM
Reposted by Jimmy
🩸 A fresh review on ITP for #hemesky #MedSky #IMsky #hemepath #ITP #lowplatelets

American Journal of Hematology | Blood Research Journal | Wiley Online Library
doi.org/10.1002/ajh....
2025 update on clinical trials in immune thrombocytopenia
Summary of major novel and repurposed agents currently in clinical development for immune thrombocytopenia.
doi.org
November 26, 2024 at 2:46 PM
Reposted by Jimmy
If we ignore Duffy-null associated neutrophil counts (DANC), we contribute to major disparities in oncology care and clinical trial enrollment. Whether you’re a clinical trialist or clinician, a must-read from @laurenmerzmd.bsky.social and coauthors #medsky #hemesky 🩸🧪

www.nejm.org/doi/abs/10.1...
The Duffy Null Phenotype — Addressing a Source of Discrimination in Cancer Care | NEJM
Cancer research and care practices that adversely affect people with the Duffy null phenotype are an underrecognized and widespread source of discrimination against people of African or Arab ancestry.
www.nejm.org
November 25, 2024 at 9:34 PM
Reposted by Jimmy
ASCT in CR1 MCL MRD-adapted #ASH24 @timfenske:
650 pts, 73% AraC induction, mFU 2.7 yr
- A: uMRD6 ASCT + MR x 3 yr
- B: uMRD6 MR x 3 yr
3-yr PFS/OS:
- A: 76.6%/82.1%
- B: 77.4%/82.7%
No difference in OS based on futility analysis. CR1 with MRD-neg at 10-6 do not need ASCT! #lymsm
November 25, 2024 at 8:43 PM
Reposted by Jimmy
10-15% of iTTP do not respond to rituximab. Targeting plasma cells can be promising.

In this study, durable responses to bortezomib were registered in 60% of multi-refractory iTTP patients, with mild-to-moderate toxicities.

www.jthjournal.org/article/S153...

#MedSky #HemeSky #TTP #bortezomib
November 23, 2024 at 10:09 AM